儿童与成人突发性感音神经性聋的疗效相当
该回顾性队列研究纳入2008年至2022年1947例单侧特发性突发性感音神经性聋住院患者(儿童219例,成人1728例),均按中国指南治疗。经倾向性评分匹配后,儿童与成人完全恢复率(18.7% vs. 16.4%)和总有效率(52.5% vs. 54.1%)相当,共享主要预后因素,治疗窗口分别为14天和15天。
要点
- 儿童与成人单侧特发性SSNHL的完全恢复率和总有效率相当。
- 两组共享预后因素:听力图构型、听力损失程度和发病至治疗时间。
- 早期干预是关键,理想在症状出现2周内开始治疗。
核心结论
- 儿童与成人单侧特发性SSNHL共享主要预后因素,在适当治疗下疗效相当。
研究设计与样本
- 所有患者按中国SSNHL指南接受住院治疗,儿童剂量按年龄和体重调整。
主要发现
- 基线中位年龄儿童13岁(IQR 10-15),成人43岁(IQR 33-50)。
- 匹配后儿童与成人完全恢复率分别为18.7%和16.4%,总有效率分别为52.5%和54.1%。
- 治疗窗口儿童为14天,成人为15天。
- 发病至治疗时间在预测模型中最具影响力,儿童AUC为0.849,成人AUC为0.901。
关键数值与推荐
- 儿童治疗窗口为14天,成人为15天。
临床怎么用
- 对儿童和成人单侧特发性SSNHL应尽早干预,理想在症状出现2周内开始治疗。
- 儿童与成人可采用相似的预后评估因素,包括听力图构型、听力损失程度和发病至治疗时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify prognostic factors for unilateral idiopathic sudden sensorineural hearing loss (SSNHL) in pediatric and adult patients, and to compare therapeutic efficacy between these age groups: METHODS: This retrospective cohort study included 1947 hospitalized patients (219 pediatric, 1728 adult) with unilateral idiopathic SSNHL from January 2008 to December 2022. All patients received inpatient therapy following the Chinese Guidelines for SSNHL, with pediatric dosing adjusted for age and weight. To compare therapeutic outcomes, multivariable logistic regression, full propensity score matching (PSM), restricted cubic spline (RCS), and machine learning algorithms were employed. RESULTS: Baseline median ages were 13 (IQR, 10-15) years for pediatric and 43 (IQR, 33-50) years for adult patients. Shared independent prognostic factors in both groups included audiogram configuration, degree of hearing loss, and treatment-onset time. Furthermore, after matching, pediatric and adult patients had comparable complete recovery (18.7% vs. 16.4%) and overall efficacy rates (52.5% vs. 54.1%). The therapeutic window was identified as 14 days for children and 15 days for adults. Consistent with this, treatment-onset time emerged as the most influential feature in predictive models, with pediatric outcomes achieving an area under the curve (AUC) of 0.849 and adult outcomes an AUC of 0.901. CONCLUSIONS: Pediatric and adult patients with unilateral idiopathic SSNHL share major prognostic factors. Therapeutic efficacy is comparable between groups when appropriate treatment is provided. Early intervention, ideally within 2 weeks of symptom onset, is critical to maximize auditory recovery.
引用
- Shan C, Zhang J, Zhou X, et al. Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss. Laryngoscope. 2026. PMID: 41537280. doi:10.1002/lary.70371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。